Pharmaceuticals Companies
Explore Pharmaceutical companies developing, manufacturing, and marketing medicines, therapeutics, vaccines, and healthcare products.
Sorted by Revenue (Highest to Lowest). Click any column header to re-sort.
| S.No. | Company Profile | Revenue | Operating Profit | Operating Cash Flow | ROE | Cash ROE | Updated | Action |
|---|---|---|---|---|---|---|---|---|
| 1. | Pfizer Inc. (NYSE: PFE) | $62.58 B | $7.79 B | $11.70 B | 8.99 % | 13.53 % | Oct 28, 2026 | View Data |
| 2. | AbbVie Inc. (NYSE: ABBV) | $61.16 B | $15.08 B | $19.03 B | — | — | Oct 27, 2026 | View Data |
| 3. | Eli Lilly and Company (NYSE: LLY) | $45.04 B | — | $12.00 B | 31.41 % | 35.59 % | Oct 20, 2026 | View Data |
| 4. | Abbott Laboratories (NYSE: ABT / NYSE Texas: ABT) | $44.33 B | $8.05 B | $9.57 B | — | — | Oct 28, 2026 | View Data |
| 5. | Gilead Sciences, Inc. (NASDAQ: GILD) | $28.80 B | — | — | — | — | Oct 20, 2026 | View Data |
| 6. | Johnson & Johnson (NYSE: JNJ) | $25.40 B | — | $24.53 B | 32.87 % | 30.08 % | Oct 30, 2026 | View Data |
| 7. | Bristol-Myers Squibb Company (NYSE: BMY) | — | — | — | — | — | Oct 20, 2026 | View Data |
| 8. | Merck & Co., Inc. (NYSE: MRK) | — | — | — | — | — | Oct 20, 2026 | View Data |
| 9. | Novo Nordisk A/S (CPH: NOVO-B) | — | — | — | — | — | Oct 20, 2026 | View Data |
| 10. | Roche Holding AG (SWX: ROG) | — | — | — | — | — | Oct 20, 2026 | View Data |